OR WAIT null SECS
November 16, 2017
Bayer will make a $400-million upfront payment to develop and commercialize two anti-cancer compounds in Loxo Oncology’s portfolio.
November 15, 2017
Despite the challenges and high cost of development, vaccine innovation is at an all-time high, as new approaches aim to improve global access.
November 09, 2017
The company has officially opened a local brand office in South Korean to support its existing business in the region.
October 27, 2017
As part of the $900-million deal, Incyte will pay $150 million upfront to develop and commercialize an anti-PD-1 drug candidate from biopharmaceutical company, MacroGenics.
October 25, 2017
Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines.
October 16, 2017
The new center will serve as a regional hub where scientists and engineers can work with customers for biological development.
October 11, 2017
The company is considering options for a full or partial separation of its Consumer Healthcare business, either through a spin-off, sale, or other transaction.
October 02, 2017
Reeling from financial and tropical storms, Puerto Rico needs stable industry for recovery.
September 25, 2017
Biopharmaceutical companies developing new competitive biotech therapies have pressed hard for clarity on the testing and data required by FDA to gain market approval of biosimilars that can be filled by a pharmacist without prescriber preapproval.
September 02, 2017
Faced with divisive political and social issues, Congress must find a way to reach consensus.